Global Hysterectomy Device Market is valued approximately USD 328.1 billion million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.6% over the forecast period 2022-2029. Hysterectomy devices are medical equipment used in the surgical extraction of the uterus. The instruments used in hysterectomies, a common gynecological treatment, can differ based on the kind of surgery carried out. This can be done for a number of reasons, including the treatment of some cancers or gynecological disorders such as uterine fibroids, endometriosis, and irregular uterine bleeding. Numerous surgical procedures, such as open surgery, laparoscopic surgery, and robotic-assisted surgery, can be used to accomplish hysterectomies. The patient’s medical history, the cause for of the hysterectomy, and the surgeon’s preference all play a role in the surgical procedure selection. The growing prevalence of uterine cancer, which generally requires treatment by hysterectomy, is one of the market trends for hysterectomy devices that is expected to boost demand for these products. Additionally, the trend toward minimally invasive surgery has raised the use of minimally invasive hysterectomy devices, such as laparoscopic devices and robotic-assisted surgical systems, which further propels the market’s expansion. Medical device producers are investing in the development of new and better tools to meet the growing demand for minimally invasive procedures. Since minimally invasive procedures are associated with shorter hospital stays, quicker recovery times, and fewer painful and scarring side effects, they are becoming more popular.
However, the rising prevalence of uterine cancer is anticipated to create the a lucrative demand for the hysterectomy device for the treatment that support supports the market growth during the forecast period. According to the Mayo Foundation for Medical Education and Research, the most common gynecologic cancer is uterine cancer. By 2030, there will likely be 122,000 new cases identified, up from an about 65,950 in 2022. The National Cancer Institute estimates that 12,550 Americans will die from this disease in 2022. Additionally, technological advancements and rising investments in hysterectomy devices are anticipated to create the lucrative opportunity for the market during forecast period. However, the availability of alternative treatments stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Hysterectomy Device Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the surge in the prevalence of uterine cancer, the presence of several key players, such as JhonsonJohnson & JhonsonJohnson, CooperCompaniesCooper Companies, and technological advancements in the region. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as the rising prevalence of uterine cancer, growing health carehealthcare expenditure and rising government investment in the healthcare sector would create lucrative growth prospects for the Hysterectomy Device market across Asia Pacific region.
Major market player included in this report are:
fortimedix surgical b.v.
B. Braun Melsungen AG
Conkin surgical instruments ltd
Richard Wolf GmbH
Johnson & Johnson Pvt. Ltd.
Cooper Companies, Inc.
KARL STORZ SE & Co. KGKARL STORZ GmbH & Co. KG
Recent Developments in the Market:
In March 2021, The Hominis device for transvaginal hysterectomy from Memic Innovative Surgery was approved for marketing, according to the FDA. According to an FDA press release, Hominis is the first robotically assisted surgical tool approved by the FDA for transvaginal hysterectomy with an indication for benign hysterectomy with salpingo-oophorectomy.
Global Hysterectomy Device Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Disease Type, End User, Surgical approach, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Disease Type:
Chronic pelvic pain
By End User:
Ambulatory Surgical Centers
By Surgical approach:
Robotic assisted laparoscopic hysterectomy
Rest of the World